111 related articles for article (PubMed ID: 887640)
1. Biopharmaceutics of aminophylline suppositories. II. In vitro release rate during storage.
de Blaey CJ; Rutten-Kingma JJ
Pharm Acta Helv; 1977; 52(1-2):11-4. PubMed ID: 887640
[No Abstract] [Full Text] [Related]
2. Biopharmaceutics of aminophylline suppositories. I. Introduction and in vitro melting behaviour.
de Blaey CJ; Rutten-Kingma JJ
Pharm Acta Helv; 1976; 51(6):186-92. PubMed ID: 959247
[No Abstract] [Full Text] [Related]
3. Theophylline versus aminophylline in rectal administration.
Touitou E; Yosselson-Superstine S
J Clin Hosp Pharm; 1985 Jun; 10(2):211-7. PubMed ID: 4019794
[TBL] [Abstract][Full Text] [Related]
4. Pulsed proton NMR and solid-liquid fat ratio determinations in suppository vehicles and aminophylline suppositories.
De Blaey CJ; Varkevisser FA; Kalk A
Pharm Weekbl Sci; 1984 Oct; 6(5):203-8. PubMed ID: 6504688
[TBL] [Abstract][Full Text] [Related]
5. Release and rectal absorption of aminophylline suppositories prepared in a hospital pharmacy.
Fujii T; Kubota A; Mizushima N
Tokai J Exp Clin Med; 1982 Sep; 7(5):539-46. PubMed ID: 7182946
[TBL] [Abstract][Full Text] [Related]
6. [Effect of method of preparation on pharmaceutical availability of aminophylline suppositories].
Knapczyk J; Starosta B; Bitner J
Folia Med Cracov; 1979; 21(1):149-56. PubMed ID: 396189
[No Abstract] [Full Text] [Related]
7. [Changes in the pharmaceutical and biological availability of aminophylline from suppositories containing non-ionogenic surface-active agents after a year of storage].
Bartkowicz S; Pawlik T; Krówczyński L; Gudowska T; Gacek M
Acta Pol Pharm; 1985; 42(2):165-71. PubMed ID: 4083053
[No Abstract] [Full Text] [Related]
8. [Pharmaceutical and biological availability of theophylline from suppositories with or without aminophylline and with the addition of aerosil].
Masiakowski J; Cieszyński T; Dyderski S; Perz A
Acta Pol Pharm; 1984; 41(2):253-7. PubMed ID: 6097098
[No Abstract] [Full Text] [Related]
9. [Biopharmaceutical evaluation of aminophylline suppositories. II. Biological availability of aminophylline (theophylline) from suppositories with normal and prolonged time of total deformation].
Masiakowski J; Cieszyński T; Dyderski S; Perz A
Acta Pol Pharm; 1984; 41(1):105-10. PubMed ID: 6496133
[No Abstract] [Full Text] [Related]
10. [Pharmaceutical and biological availability of aminophylline in suppositories containing non-ionic surface-active agents].
Bartkowicz S; Pawlik T; Rosiek-Pawłowska A
Folia Med Cracov; 1979; 21(1):179-91. PubMed ID: 540870
[No Abstract] [Full Text] [Related]
11. [Biopharmaceutical evaluation of aminophylline suppositories. I. Pharmacological parameters of theophylline from aminophylline suppositories with normal and prolonged time of total deformation].
Masiakowski J; Cieszyński T; Dyderski S; Perz A
Acta Pol Pharm; 1984; 41(1):99-104. PubMed ID: 6496143
[No Abstract] [Full Text] [Related]
12. Aminophylline suppositories and sustained-release tablets compared in bronchospasm.
Ross AE
Practitioner; 1981 Jul; 225(1357):1061-2. PubMed ID: 7031630
[No Abstract] [Full Text] [Related]
13. [The consequence of the preparation factors for the effect of the drug].
Johnsgård M; Pedersen AO
Tidsskr Nor Laegeforen; 1973 Apr; 93(10):698-703. PubMed ID: 4755086
[No Abstract] [Full Text] [Related]
14. In vitro kinetics of drug release from oral dosage forms, lyophilized and conventional rectal suppositories. I. Mathematical considerations applicable to a two compartment open model system simulating more realistic in vivo conditions.
Bhavnagri VP; Speiser P
Pharm Acta Helv; 1975; 50(9):279-82. PubMed ID: 1178726
[No Abstract] [Full Text] [Related]
15. Prolonged storage of aminophylline suppositories. The impact on physical parameters and bioavailability.
Tukker JJ; De Blaey CJ
Pharm Weekbl Sci; 1984 Apr; 6(2):96-8. PubMed ID: 6728641
[TBL] [Abstract][Full Text] [Related]
16. Biopharmaceutical investigations of rectal suppositories. Part 1: Pharmaceutical and biological availability of theophylline.
Minkov E; Lambov N; Kirchev D; Bantutova I; Tencheva J
Pharmazie; 1984 Apr; 39(4):242-3. PubMed ID: 6547533
[TBL] [Abstract][Full Text] [Related]
17. New labeling for aminophylline rectal suppositories.
FDA Drug Bull; 1980 Nov; 10(3):24. PubMed ID: 7450337
[No Abstract] [Full Text] [Related]
18. [Application and dosage of aminophylline in suppositories].
de Smet PA; Jonkman JH
Ned Tijdschr Geneeskd; 1981 Dec; 125(50):2059-63. PubMed ID: 7322225
[No Abstract] [Full Text] [Related]
19. [Storage stability of rectal dosage forms].
Voigt R; Bornschein M; Grohmann A
Pharmazie; 1982 Jul; 37(7):529-36. PubMed ID: 6752967
[No Abstract] [Full Text] [Related]
20. Correlation between in vitro release of Proxyphylline from suppositories and in vivo data obtained from cumulative urinary excretion studies.
Ritschel WA; Banarer M
Arzneimittelforschung; 1973 Aug; 23(8):1031-5. PubMed ID: 4801021
[No Abstract] [Full Text] [Related]
[Next] [New Search]
